10x Genomics Reports Preliminary Q3 2024 Results Overview
10x Genomics Reveals Early Third Quarter 2024 Financials
10x Genomics, Inc. (NASDAQ: TXG), a leader in single cell and spatial biology innovations, has shared preliminary results for its third quarter of 2024. These results reflect the company's ongoing commitment to transforming the landscape of life sciences, particularly amidst shifting market dynamics.
Revenue Insights for the Third Quarter
According to the announcement, the revenue for the third quarter is estimated to be around $151.7 million. This figure marks a slight decrease of approximately 1% compared to the same timeframe last year. The company is actively analyzing various aspects of its financial performance, aiming for clear insights into revenue streams.
Breakdown of Revenue Sources
Delving deeper, the revenue experienced varied shifts across different sources. Here’s a quick overview of the expected revenue by source:
- Instruments Revenue: Estimated at $19.1 million, reflecting a significant decrease of 46% compared to the previous year's third quarter. This consists of about $7.6 million from Chromium instruments and $11.4 million from Spatial instruments.
- Consumables Revenue: Showcased a positive trajectory with around $126.2 million, indicating a growth of 10% over the previous year. This included around $96.5 million from Chromosomes and $29.7 million from Spatial consumables.
- Services Revenue: Estimated at $6.4 million, exhibiting a strong growth rate of 48% year-over-year.
Geographic Revenue Distribution
The report also highlighted revenue distribution by geography:
- Americas: Revenue expected to be about $87.8 million, an 11% decline compared to last year's figures.
- EMEA: Anticipated revenue of approximately $37.9 million, showing an 18% increase from the same period last year.
- APAC: Estimated revenue of $26.0 million, displaying a 15% increase year-over-year.
Cash Reserves and Future Outlook
10x Genomics reported cash and cash equivalents totaling approximately $398 million. This robust cash reserve puts the company in a favorable position to navigate the ongoing challenges and invest in future growth opportunities.
Comments from Leadership
In light of these results, CEO Serge Saxonov remarked, "While our revenue did not meet expectations this quarter, we are undergoing significant changes in our commercial approaches and how we engage customers. Although the transition has been more disruptive than expected, particularly in the Americas, we remain positive about the future opportunities. We believe that our strategies will eventually enhance customer engagement and broaden the access to our pioneering technologies."
Adjustment of Preliminary Results
The preliminary financials disclosed are still subject to adjustment as 10x Genomics finalizes its third quarter statements. It is vital to understand that the results can change as more data becomes available, especially as they conclude their customary reviews for accuracy.
2024 Financial Guidance and Upcoming Events
Investors and stakeholders can look forward to more comprehensive insights when 10x Genomics shares its full-year 2024 financial guidance during the earnings call scheduled for the end of the month. This call will provide a platform for discussing not just third-quarter results, but also future expectations.
Webcast and Conference Call Details
The company invites interested parties to join the conference call to delve into its performance, developments, and outlook. This call will occur after market closure. Furthermore, a recorded version will be available for replay for those unable to attend live.
About 10x Genomics
10x Genomics is a pioneering life science technology firm committed to advancing biological understanding and improving human health. They offer integrated solutions that encompass instruments, consumables, and specialized software tailored for single cell and spatial biology. Their groundbreaking products have facilitated significant advancements across various fields including oncology and neuroscience.
Frequently Asked Questions
What were 10x Genomics' total revenues for Q3 2024?
The total revenue for Q3 2024 is expected to be approximately $151.7 million, representing a 1% decrease from the previous year.
How did 10x Genomics perform financially in different regions?
In the Americas, revenue dropped by 11%, while EMEA and APAC regions saw increases of 18% and 15%, respectively.
What challenges are impacting 10x Genomics' revenue?
Challenges include a cautious spending approach from customers, particularly regarding capital purchases and ongoing adjustments to commercial strategies.
When will 10x Genomics disclose its full-year 2024 guidance?
The full-year guidance will be shared during the earnings call on October 29, 2024.
How can I access the webcast of the earnings call?
The webcast of the earnings call will be available on the company's investor relations website, offering a detailed look into their performance and strategic direction.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
Disclaimer: The content of this article is solely for general informational purposes only; it does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice; the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. The author's interpretation of publicly available data shapes the opinions presented here; as a result, they should not be taken as advice to purchase, sell, or hold any securities mentioned or any other investments. The author does not guarantee the accuracy, completeness, or timeliness of any material, providing it "as is." Information and market conditions may change; past performance is not indicative of future outcomes. If any of the material offered here is inaccurate, please contact us for corrections.
Related Articles
- Class Action Overview for Investors: AMMO, Iris Energy, Terran
- GBank Financial Holdings Set for Q3 Earnings Call This October
- Banco Itaú Chile Prepares for Q3 2024 Financial Disclosure
- Itaú Chile Prepares for Third Quarter Financial Results Call
- ThreeD Capital Inc. Reports September 2024 Net Asset Value Insights
- ThreeD Capital Inc. Reports Growth in September NAV Per Share
- Applying Preliminary Ratings to the Latest Auto Receivables Trust
- Franklin Resources Reports Trillion-Dollar Assets Assessment
- Analysis of Multifamily Rent Trends in Q3 2024 from Apartments.com
- Teck Resources Recognized Among World's Top Employers in 2024
Recent Articles
- Aimco Reaches Deal to Sell Major Investments in Miami Area
- Horizon Aircraft Showcases Innovative Hybrid eVTOL at Japan Event
- SM Energy Plans to Release Third Quarter Earnings Soon
- Costco Wholesale Corporation Highlights Strong September Sales Growth
- Ally Financial Announces Quarterly Dividend for Stockholders
- Groundbreaking Presentation by ORIC Pharmaceuticals at Symposium
- Tragic Missile Strike in Odesa: Lives Lost and Infrastructure Damaged
- The Clorox Company Set to Share Q1 Fiscal Results on Webcast
- DHT Holdings, Inc. Reveals Insightful Business Developments
- BCSAU Stock Soars to New Heights with 52-Week Peak
- Titan International Prepares to Share Q3 Results Next Week
- Plexus Announces Earnings Release Date for 2024 Fiscal Year
- Alerus Financial's Growth: Major Acquisition and Dividend Increase
- FS Credit Opportunities Corp. Announces Upcoming Distributions
- Certara Plans to Announce Third Quarter Financial Outcomes
- Ardelyx Expands Its Operational Reach with New Lease Agreement
- AZZ Inc. Announces Strong Fiscal Performance for Q2 FY2025
- Bel Fuse to Announce Financial Results Conference Call Soon
- Gatos Silver Achieves Significant Growth in Silver Production
- 10x Genomics Shows Resilience Amidst Revenue Challenges
- Black Hills Corp. Announces Upcoming Q3 2024 Earnings Call
- Qualcomm Welcomes Hewlett Packard CFO Marie Myers to the Board
- GAC Unveils Exciting EV Innovations at Upcoming Motorshow
- RCP Advisors Shines Bright with Top Rankings from PitchBook
- NPFD Stock Hits New Heights with 52-Week Record of $19.2
- Artisan Partners Announces Record Assets Under Management
- Oil-Dri Corporation Announces Stock Split for Enhanced Value
- Minim, Inc. Secures Extension in NASDAQ Delisting Case
- Launch Two Acquisition Corp. Makes Major Market Debut with IPO
- APA Corporation Q3 Financial Report: Gains, Sales, and Future Plans
- FormFactor Set to Reveal Q3 2024 Financial Results Soon
- Maximizing AI Stock Investments Amid October's Tech Volatility
- Replimune Expands Team with Inducement Equity Grants
- Indigenous Voices Unheard in Brazilian Carbon Credit Deal
- PROCEPT BioRobotics Set to Announce Q3 2024 Financials Soon
- Applied Digital Sees Revenue Surge but Stock Takes a Hit
- Duolingo's Exciting Q3 2024 Results to be Revealed Soon
- Latham Group Welcomes New Board Member Enhancing Leadership
- LPL Financial Prepares for Q3 2024 Results and Discussion
- Horizon Technology Finance's Q3 2024 Growth Insights
- Applied Digital Achieves Impressive Growth in Q1 2025
- Nextracker Plans Fiscal 2025 Q2 Financial Results Announcement
- Smith Douglas Homes to Announce Q3 2024 Earnings Call Details
- Encore Capital Group Prepares for Q3 2024 Financial Release
- Public Storage Plans Q3 2024 Earnings Call for Investors
- Exciting Updates from Floor & Decor's Q3 2024 Earnings Call
- Appian's Upcoming Financial Results and Strategic Insights
- Adaptive Biotechnologies' Upcoming Financial Results Announcement
- Green Brick Partners Set to Announce Q3 Earnings Call Details
- Avista Corp. Set to Announce Exciting Q3 Earnings Call